Form follows function: Advances in trilayered structure replication for aortic heart valve tissue engineering

Journal of Healthcare Engineering

Volumn 3, Issue 2, 2012, Pages 179-202

  Simionescu, Dan T ^b   Chen, Joseph ^c   Jaeggli, Michael ^b   Wang, Bo ^a   Liao, Jun ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b AMRL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Bioreactor; Heart valve tissue engineering; Long term durability; Microstructural fatigue; Tissue remodeling; Trilayered structure replication

Indexed keywords

EID: 84864051113     PISSN: 20402295     EISSN: 20402309     Source Type: Journal    
DOI: 10.1260/2040-2295.3.2.179     Document Type: Review

References (140)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010, 121(7):948-54.
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010, 121(7):e46-e215.
3. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007, 50(13):1205-13.
4. Yacoub M. Viewpoint: Heart valve engineering. Interview by James Butcher. Circulation. 2007,116(8):f44-6.
5. Filova E, Straka F, Mirejovsky T, Masin J, Bacakova L. Tissue-engineered heart valves. Physiol Res. 2009,58 Suppl 2:S141-58.
6. Hjortnaes J, Bouten CV, Van Herwerden LA, Grundeman PF, Kluin J. Translating autologous heart valve tissue engineering from bench to bed. Tissue Eng Part B Rev. 2009, 15(3):307-17.
7. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng. 2009, 11:289-313.
8. Mol A, Rutten MC, Driessen NJ, Bouten CV, Zund G, Baaijens FP, Hoerstrup SP. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation. 2006, 114(1 Suppl):I152-8.
9. Mol A, Smits AI, Bouten CV, Baaijens FP. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices. 2009, 6(3):259-75.
10. Baaijens F, Bouten C, Hoerstrup S, Mol A, Driessen N, Boerboom R. Functional tissue engineering of the aortic heart valve. Clin Hemorheol Microcirc. 2005, 33(3):197-9.
11. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004, 10(11-12):1725-36.
12. Mol A, Bouten CV, Baaijens FP, Zund G, Turina MI, Hoerstrup SP. Review article: Tissue engineering of semilunar heart valves: current status and future developments. J Heart Valve Dis. 2004, 13(2):272-80.
13. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng. 2006, 34(12):1799-819.
14. Gandaglia A, Bagno A, Naso F, Spina M, Gerosa G. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardiothorac Surg. 2011, 39(4):523-31.
15. Jordan JE, Williams, J.K., Lee, S.J., Raghavan D., Atala, A.J., Yoo, J.J. In Situ Regeneration of Heart Valves: A Novel, Rapid Method for Tissue Engineering Heart Valves. The Western Thoracic Surgical Association. 2011.
16. Sacks MS, Yoganathan AP. Heart valve function: a biomechanical perspective. Philos Trans R Soc Lond B Biol Sci. 2007, 362(1484):1369-91.
17. Sacks MS, David Merryman W, Schmidt DE. On the biomechanics of heart valve function. J Biomech. 2009, 42(12):1804-24.
18. Butcher JT, Simmons CA, Warnock JN. Mechanobiology of the aortic heart valve. J Heart Valve Dis. 2008, 7(1):62-73.
19. Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003, 12(2):226-34.
20. Simionescu DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003, 12(2):217-25.
21. Simionescu DT, Lovekamp JJ, Vyavahare NR. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res. 2003, 66A(4):755-63.
22. Latif N, Sarathchandra P, Thomas PS, Antoniw J, Batten P, Chester AH, Taylor PM, Yacoub MH. Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. J Heart Valve Dis. 2007, 16(1):56-66.
23. Ku CH, Johnson PH, Batten P, Sarathchandra P, Chambers RC, Taylor PM, Yacoub MH, Chester AH. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res. 2006, 71(3):548-56.
24. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol. 2003, 35(2):113-8.
25. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007, 171(5):1407-18.
26. Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, Kronsteiner A, Defelice S, Xu J, Ohri R, Narula N, Vyavahare N, Levy RJ. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol. 2005, 166(1):1-13.
27. Simionescu DT, Lu Q, Song Y, Lee JS, Rosenbalm TN, Kelley C, Vyavahare NR. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006, 27(5):702-13.
28. Yip CY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 2009, 29(6):936-42.
29. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006, 126(4):677-89.
30. Engler AJ, Sweeney HL, Discher DE, Schwarzbauer JE. Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact. 2007, 7(4):335.
31. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation. 2002, 106(12 Suppl 1):I143-50.
32. Schmidt D, Breymann C, Weber A, Guenter CI, Neuenschwander S, Zund G, Turina M, Hoerstrup SP. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg. 2004, 78(6):2094-8.
33. Hoerstrup SP, Kadner A, Breymann C, Maurus CF, Guenter CI, Sodian R, Visjager JF, Zund G, Turina MI. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg. 2002, 74(1):46-52.
34. Sarugaser R, Ennis J, Stanford WL, Davies JE. Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods Mol Biol. 2009, 482:269-79.
35. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells. 2004, 22(7):1330-7.
36. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng. 2003, 9(3):487-93.
37. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, Painter C, Mirensky T, Erickson B, Shinoka T, Breuer CK. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010, 16(3):341-50.
38. Pawlowski KJ, Rittgers SE, Schmidt SP, Bowlin GL. Endothelial cell seeding of polymeric vascular grafts. Front Biosci. 2004, 9:1412-21.
39. Sagnella S, Anderson E, Sanabria N, Marchant RE, Kottke-Marchant K. Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin. Tissue Eng. 2005, 11(1-2):226-36.
40. Bowlin GL, Meyer A, Fields C, Cassano A, Makhoul RG, Allen C, Rittgers SE. The persistence of electrostatically seeded endothelial cells lining a small diameter expanded polytetrafluoroethylene vascular graft. J Biomater Appl. 2001, 16(2):157-73.
41. Ferrell N, Gallego-Perez D, Higuita-Castro N, Butler RT, Reen RK, Gooch KJ, Hansford DJ. Vacuumassisted cell seeding in a microwell cell culture system. Anal Chem. 2010, 82(6):2380-6.
42. Hsu SH, Tsai IJ, Lin DJ, Chen DC. The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys. 2005, 27(3):267-72.
43. Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR, Sutherland FW, Perry T, Ochoa E, Thompson CA, Mayer JE, Jr., Oesterle SN, Vacanti JP. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng. 2003, 9(2):291-9.
44. Perea H, Aigner J, Hopfner U, Wintermantel E. Direct magnetic tubular cell seeding: a novel approach for vascular tissue engineering. Cells Tissues Organs. 2006, 183(3):156-65.
45. Shimizu K, Ito A, Arinobe M, Murase Y, Iwata Y, Narita Y, Kagami H, Ueda M, Honda H. Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. J Biosci Bioeng. 2007, 103(5):472-8.
46. van Wachem PB, Stronck JW, Koers-Zuideveld R, Dijk F, Wildevuur CR. Vacuum cell seeding: a new method for the fast application of an evenly distributed cell layer on porous vascular grafts. Biomaterials. 1990, 11(8):602-6.
47. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000, 102(19 Suppl 3):III50-5.
48. Konertz W, Dohmen PM, Liu J, Beholz S, Dushe S, Posner S, Lembcke A, Erdbrugger W. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis. 2005, 14(1):78-81.
49. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation. 2002, 106(12 Suppl 1):I63-I8.
50. Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl). 2007, 120(8):696-702.
51. Lopes SA, Costa FD, Paula JB, Dhomen P, Phol F, Vilani R, Roderjan JG, Vieira ED. Decellularized heterografts versus cryopreserved homografts: experimental study in sheep model. Rev Bras Cir Cardiovasc. 2009, 24(1):15-22.
52. Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg. 2004, 127(2):399-405.
53. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, Wolner E, Simon P, Weigel G. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation. 2005, 111(21):2792-7.
54. Zhao DE, Li RB, Liu WY, Wang G, Yu SQ, Zhang CW, Chen WS, Zhou GX. Tissue-engineered heart valve on acellular aortic valve scaffold: in-vivo study. Asian Cardiovasc Thorac Ann. 2003, 11(2):153-6.
55. Gui L, Muto A, Chan SA, Breuer CK, Niklason LE. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A. 2009, 15(9):2665-76.
56. Korossis SA, Booth C, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis. 2002, 11(4):463-71.
57. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003, 23(6):1002-6.
58. Williams C, Liao J, Joyce EM, Wang B, Leach JB, Sacks MS, Wong JY. Altered structural and mechanical properties in decellularized rabbit carotid arteries. Acta Biomater. 2009, 5(4):993-1005.
59. Chuang TH, Stabler C, Simionescu A, Simionescu DT. Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A. 2009, 15(10):2837-51.
60. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Meiser B, Reichart B. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg. 2003, 125(3):592-601.
61. Gulbins H, Pritisanac A, Pieper K, Goldemund A, Meiser BM, Reichart B, Daebritz S. Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model. Ann Thorac Surg. 2006, 81(4):1472-9.
62. Moritz A, Grimm M, Eybl E, Grabenwoger M, Windberger U, Dock W, Bock P, Wolner E. Improved biocompatibility by postfixation treatment of aldehyde fixed bovine pericardium. ASAIO Trans. 1990, 36(3):M300-3.
63. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis. 2000, 9(2):230-40.
64. Sierad LN, Simionescu A, Albers C, Chen J, Maivelett J, Tedder ME, Liao J, Simionescu DT. Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves. Cardiovasc Eng Technol. 2010, 1(2):138-53.
65. Tedder ME, Liao J, Weed B, Stabler C, Zhang H, Simionescu A, Simionescu DT. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A. 2009, 15(6):1257-68.
66. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002, 11(4):457-62.
67. Stock UA, Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials. 2006, 27(1):1-2.
68. Karim N, Golz K, Bader A. The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Artif Organs. 2006, 30(10):809-14.
69. Kasimir MT, Rieder E, Seebacher G, Nigisch A, Dekan B, Wolner E, Weigel G, Simon P. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis. 2006, 15(2):278-86. discussion 86.
70. Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G, Simon P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng. 2005, 11(7-8):1274-80.
71. Kasimir MT, Weigel G, Sharma J, Rieder E, Seebacher G, Wolner E, Simon P. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost. 2005, 94(3):562-7.
72. Arai S, Lacerda C, Orton EC. Tissue-gel electrophoresis enhances antigen removal from porcine aortic valve and bovine pericardium. J Heart Valve Dis. 2010, 19(6):753-8.
73. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation. 2000, 70(1):7-14.
74. Tedder ME, Simionescu A, Chen J, Liao J, Simionescu DT. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A. 2011, 17(1-2):25-36.
75. Matheny RG, Hutchison ML, Dryden PE, Hiles MD, Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis. 2000, 9(6):769-74.
76. Vesely I. Heart valve tissue engineering. Circulation research. 2005, 97(8):743-55.
77. Butcher JT, Nerem RM. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis. 2004, 13(3):478-85.
78. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng. 2006, 12(4):905-15.
79. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, Messmer BJ, Turina M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2001, 19(4):424-30.
80. Neidert MR, Tranquillo RT. Tissue-engineered valves with commissural alignment. Tissue Eng. 2006, 12(4):891-903.
81. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials. 2005, 26(9):999-1010.
82. Rothenburger M, Vischer P, Volker W, Glasmacher B, Berendes E, Scheld HH, Deiwick M. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thorac Cardiovasc Surg. 2001, 49(4):204-9.
83. Shi Y, Ramamurthi A, Vesely I. Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum. 2002, 38:35-40.
84. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis. 2002, 11(3):298-306.
85. Taylor PM, Sachlos E, Dreger SA, Chester AH, Czernuszka JT, Yacoub MH. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. Biomaterials. 2006, 27(13):2733-7.
86. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2000, 17(5):587-91.
87. Flanagan TC, Wilkins B, Black A, Jockenhoevel S, Smith TJ, Pandit AS. A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials. 2006, 27(10):2233-46.
88. Vesely I. The role of elastin in aortic valve mechanics. J Biomech. 1998, 31(2):115-23.
89. Bense CA, Woodhouse KA. Plasmin degradation of fibrin coatings on synthetic polymer substrates. J Biomed Mater Res. 1999, 46(3):305-14.
90. Jackson MR, Alving BM. Fibrin sealant in preclinical and clinical studies. Curr Opin Hematol. 1999, 6(6):415-9.
91. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis. 1996, 7(8):737-46.
92. Grassl ED, Oegema TR, Tranquillo RT. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J Biomed Mater Res. 2002, 60(4):607-12.
93. Murata K. Acidic glycosaminoglycans in human heart valves. J Mol Cell Cardiol. 1981, 13(3):281-92.
94. Masters KS, Shah DN, Leinwand LA, Anseth KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials. 2005, 26(15):2517-25.
95. Flanagan TC, Cornelissen C, Koch S, Tschoeke B, Sachweh JS, Schmitz-Rode T, Jockenhoevel S. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials. 2007, 28(23):3388-97.
96. Flanagan TC, Sachweh JS, Frese J, Schnoring H, Gronloh N, Koch S, Tolba RH, Schmitz-Rode T, Jockenhoevel S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A. 2009, 15(10):2965-76.
97. Brody S, Pandit A. Approaches to heart valve tissue engineering scaffold design. J Biomed Mater Res B Appl Biomater. 2007, 83(1):16-43.
98. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 2006, 12(5):1197-211.
99. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, Kim BS, Schoen FJ, Vacanti JP, Mayer JE, Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000, 102(19 Suppl 3):III22-9.
100. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE, Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995, 60(6 Suppl):S513-6.
101. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE, Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996, 94(9 Suppl):II164-8.
102. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE, Jr. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circulation. 1997, 96(9 Suppl):II-102-7.
103. Ozawa T, Mickle DA, Weisel RD, Matsubayashi K, Fujii T, Fedak PW, Koyama N, Ikada Y, Li RK. Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant. 2004, 13(2):169-77.
104. Nuttelman CR, Henry SM, Anseth KS. Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials. 2002, 23(17):3617-26.
105. Engelmayr GC, Jr., Rabkin E, Sutherland FW, Schoen FJ, Mayer JE, Jr., Sacks MS. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials. 2005, 26(2):175-87.
106. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE, Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 2000, 6(1):75-9.
107. Del Gaudio C, Bianco A, Grigioni M. Electrospun bioresorbable trileaflet heart valve prosthesis for tissue engineering: in vitro functional assessment of a pulmonary cardiac valve design. Ann Ist Super Sanita. 2008, 44(2):178-86.
108. Courtney T, Sacks MS, Stankus J, Guan J, Wagner WR. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials. 2006, 27(19):3631-8.
109. Del Gaudio C, Grigioni M, Bianco A, De Angelis G. Electrospun bioresorbable heart valve scaffold for tissue engineering. Int J Artif Organs. 2008, 31(1):68-75.
110. Dohmen PM, Konertz W. Tissue-engineered heart valve scaffolds. Ann Thorac Cardiovasc Surg. 2009, 15(6):362-7.
111. Hong H, Dong GN, Shi WJ, Chen S, Guo C, Hu P. Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro. ASAIO J. 2008, 54(6):627-32.
112. Stankus JJ, Guan J, Fujimoto K, Wagner WR. Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials. 2006, 27(5):735-44.
113. Sodian R, Hoerstrup SP, Sperling JS, Martin DP, Daebritz S, Mayer JE, Jr., Vacanti JP. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO J. 2000, 46(1):107-10.
114. Sodian R, Sperling JS, Martin DP, Egozy A, Stock U, Mayer JE, Jr., Vacanti JP. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng. 2000, 6(2):183-8.
115. Chen M, Patra PK, Warner SB, Bhowmick S. Role of fiber diameter in adhesion and proliferation of NIH 3T3 fibroblast on electrospun polycaprolactone scaffolds. Tissue Eng. 2007, 13(3):579-87.
116. Li WJ, Mauck RL, Cooper JA, Yuan X, Tuan RS. Engineering controllable anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal tissue engineering. J Biomech. 2007, 40(8):1686-93.
117. Nerurkar NL, Elliott DM, Mauck RL. Mechanics of oriented electrospun nanofibrous scaffolds for annulus fibrosus tissue engineering. J Orthop Res. 2007, 25(8):1018-28.
118. Venugopal J, Low S, Choon AT, Ramakrishna S. Interaction of cells and nanofiber scaffolds in tissue engineering. J Biomed Mater Res B Appl Biomater. 2008, 84(1):34-48.
119. Talman EA, Boughner DR. Internal shear properties of fresh porcine aortic valve cusps: implications for normal valve function. J Heart Valve Dis. 1996, 5(2):152-9.
120. Talman EA, Boughner DR. Glutaraldehyde fixation alters the internal shear properties of porcine aortic heart valve tissue. Ann Thorac Surg. 1995, 60(2 Suppl):S369-73.
121. Vesely I, Boughner D. Analysis of the bending behaviour of porcine xenograft leaflets and of natural aortic valve material: bending stiffness, neutral axis and shear measurements. Journal of Biomechanics. 1989, 22(6/7):655-71.
122. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials. 2008, 29(8):1065-74.
123. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE, Jr. Functional living trileaflet heart valves grown in vitro. Circulation. 2000, 102(19 Suppl 3):III44-9.
124. da Costa FD, Costa AC, Prestes R, Domanski AC, Balbi EM, Ferreira AD, Lopes SV. The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg. 2010, 90(6):1854-60.
125. Lichtenberg A, Tudorache I, Cebotari S, Suprunov M, Tudorache G, Goerler H, Park JK, Hilfiker-Kleiner D, Ringes-Lichtenberg S, Karck M, Brandes G, Hilfiker A, Haverich A. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation. 2006, 114(1 Suppl):I559-65.
126. Oswal D, Korossis S, Mirsadraee S, Wilcox H, Watterson K, Fisher J, Ingham E. Biomechanical characterization of decellularized and cross-linked bovine pericardium. J Heart Valve Dis. 2007, 16(2):165-74.
127. Wang Q, McGoron AJ, Bianco R, Kato Y, Pinchuk L, Schoephoerster RT. In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Valve Dis. 2010, 19(4):499-505.
128. Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol. 1997, 59:575-99.
129. Maul TM, Chew DW, Nieponice A, Vorp DA. Mechanical stimuli differentially control stem cell behavior: morphology, proliferation, and differentiation. Biomech Model Mechanobiol. 2011, 10:939-953.
130. Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, Ando J. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol. 2003, 95(5):2081-8.
131. Schumann D, Kujat R, Nerlich M, Angele P. Mechanobiological conditioning of stem cells for cartilage tissue engineering. Biomed Mater Eng 2006.16(4 Suppl):S37-52.
132. Jacot JG, Martin JC, Hunt DL. Mechanobiology of cardiomyocyte development. J Biomech. 2010, 43(1):93-8.
133. Sabbah HN, Hamid MS, Stein PD. Mechanical factors in the degeneration of porcine bioprosthetic valves: an overview. J Card Surg. 1989, 4(4):302-9.
134. Haziza F, Papouin G, Barratt-Boyes B, Christie G, Whitlock R. Tears in Bioprosthetic Heart Valve Leaflets without Calcific Degeneration. Journal of Heart Valve Disease. 1996, 5:35-9.
135. Grabenwoger M, Fitzal F, Gross C, Hutschala D, Bock P, Brucke P, Wolner E. Different modes of degeneration in autologous and heterologous heart valve prostheses. J Heart Valve Dis. 2000, 9(1):104-9.
136. Rao KP, Shanthi C. Reduction of calcification by various treatments in cardiac valves. J Biomater Appl. 1999, 13(3):238-68.
137. Schoen FJ. Pathology of heart valve substitution with mechanical and tissue prostheses. In: Silver MD, Gotlieb AI, Schoen FJ, editors. Cardiovascular Pathology. New York: Livingstone. 2001.
138. Liao J, Joyce EM, Merryman WD, Jones HL, Tahai M, Horstemeyer MF, Williams LN, Hopkins RA, Sacks MS. The Intrinsic Fatigue Mechanism of the Porcine Aortic Valve Extracellular Matrix. Cardiovascular Engineering and Technology 2012. Epub Date: January 7.
139. Grande-Allen KJ, Liao J. The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering. Curr Cardiol Rep. 2011, 13(2):113-20.
140. Schoen FJ. Heart valve tissue engineering: quo vadis? Curr Opin Biotechnol. 2011, 22(5):698-705.